Sort
82,697 grants matching “vaccine development”
Translation of a highly protective tularemia vaccine to the NHP model
$824,845Karsten R.o. Hazlett · Albany Medical College · R01 · FY2024 · AI
Effect of obesity on HIV pathogenesis, antiretroviral therapy, and metabolic comorbidities
$824,832Charles T Roberts · Oregon Health & Science University · R01 · FY2022 · DK
Nipah virus vaccines and monoclonal antibodies
$824,638Nancy J Sullivan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology
$824,595Nicholas J Mantis · Wadsworth Center · U01 · FY2023 · CA
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies
$824,500Pamela J Bjorkman · California Institute Of Technology · P01 · FY2025 · AI
Humoral Correlates of Protection Against HIV
$824,344Ruth Margrit Ruprecht · Texas Biomedical Research Institute · R01 · FY2015 · AI
NOVEL HIV VACCINES
$824,329University Of Md Biotechnology Institute · P01 · FY2000 · AI
Molecular Genetics Of Scrapie Pathogenesis
$824,287Suzette Alise Priola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Early Events in Mucosal SIV Pathogenesis
$824,281Ronald S. Veazey · Tulane University Of Louisiana · R01 · FY2010 · AI
Nonhuman Primate Core Virology Laboratory for AIDS Vaccine Research and Development
$824,248Thomas Denny · Duke University · N01 · FY2024 · AI
DEVELOPMENT OF VACCINES FOR ORAL CARCINOMA
$824,210University Of Pittsburgh At Pittsburgh · P01 · FY2001 · DE
Papillomavirus Virion Proteins and Vaccines
$824,108Douglas R. Lowy · Basic Sciences · Z01 · FY2007 · CA
Peer-Driven Intervention to Enroll Minorities/Women in HIV/AIDS Clinical Trials
$824,067Marya Gwadz · National Development And Research Institutes, Inc. · R01 · FY2009 · AI
Neonatal Immunity to novel TF SHIVs
$824,062Wilton B Williams · Duke University · R37 · FY2024 · AI
Systems biological analyses of adaptive responses to vaccination
$824,038Rafi Ahmed · Emory University · U19 · FY2011 · AI
High-throughput mapping of antigen specificity to B-cell-receptor sequence for characterizing antibody responses in HIV-vaccinated and infected individuals
$823,824Ivelin Georgiev · Vanderbilt University Medical Center · R01 · FY2023 · AI
Development of an mRNA-Based Therapeutic HIV/AIDS Vaccine
$823,817Afamefuna Okoye · Oregon Health & Science University · R01 · FY2022 · AI
Examining biomarkers and mechanisms of health disparities in sexual minority women
$823,701Kathryn Elizabeth Keenan · University Of Chicago · R01 · FY2020 · HL
The Impact of Aging and HIV Infection on Immunologic and Transcriptomic Signatures of Influenza Vaccine Response
$823,522Albert C Shaw · Yale University · R01 · FY2018 · AG
Rapid Point of Care Detection of HPV-Associated Malignancies
$823,353Karen Sue Anderson · Arizona State University-Tempe Campus · UH3 · FY2021 · CA
CRYPTOCOCCUS NEOFORMANS--A MODEL FOR PATHOGENIC FUNGI
$823,347Duke University · P01 · FY2002 · AI
Development of a Universal Vaccine Against Leptospirosis
$823,327Elsio Augusto Wunder · University Of Connecticut Storrs · R01 · FY2024 · AI
Exploratory Human Trials of Combination Rectal Microbicides
$823,265Ian Michael McGowan · Magee-Women'S Res Inst And Foundation · U19 · FY2010 · AI
Mechanisms of mucosal protection induced by attenuated SIV
$823,181R. Paul Johnson · Harvard Medical School · P01 · FY2010 · AI
Modulation of the early host response to SIV in pathogenic infection
$823,087Amitinder Kaur · Harvard Medical School · R01 · FY2009 · AI